YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 13, 16:00
627.40
8.25 (1.33%)
VOLUME 233,796
LIVE
NSE
Apr 13, 15:59
627.35
8 (1.29%)
VOLUME 7,399,207
News on Sun Pharmaceutical Industries
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sun Pharma Q4 PAT seen up 82.2% YoY to Rs. 1,462.7 cr: Sharekhan

8.40 pm | 12 Apr 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 6.2 percent Y-o-Y (down 1.6 percent Q-o-Q) to Rs. 8,692.6 crore, according to Sharekhan....

Buy Sun Pharmaceutical Industries: target of Rs 700: Sharekhan

2.19 pm | 05 Apr 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 700 in its research report dat...

Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market

11.29 am | 14 Mar 2021 |  Source: PTI

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Sun Pharma is recalling Cequa ophthalmic solution, which is used ...

Sun Pharma share price rise over 2% after arm acquires stake in WRS Bioproducts

3.06 pm | 10 Mar 2021 |  Source: Moneycontrol.com

The share touched a 52-week high of Rs 653.70 and a 52-week low of Rs 315.20 on 12 February, 2021 and 23 March, 2020, respectively....

Quant Pick - Sun Pharmaceuticals: ICICI Direct

1.39 pm | 05 Mar 2021 |  Source: Moneycontrol.com

According to ICICI Direct, Buy Sun Pharmaceuticals in range of Rs 625-635 Target: Rs 738 Stop Loss: Rs 570 Time frame: Three months....

Buy Sun Pharmaceutical Industries; target of Rs 700: Sharekhan

10.53 pm | 09 Feb 2021 |  Source: Moneycontrol.com

Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 700 in its research report dat...

Buy Sun Pharmaceutical Industries; target of Rs 672: Prabhudas Lilladher

8.56 pm | 05 Feb 2021 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 672 in its research ...

Buy Sun Pharmaceutical Industries; target of Rs 675: ICICI Direct

7.11 pm | 05 Feb 2021 |  Source: Moneycontrol.com

ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 675 in its research report ...

Hold Sun Pharmaceutical Industries; target of Rs 602: Prabhudas Lilladher

6.44 pm | 04 Feb 2021 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 602 in its research report dated January 28, 20...

Buy Sun Pharma; target of Rs 740: Motilal Oswal

8.46 pm | 03 Feb 2021 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 740 in its research report dated January 30, ...

Sun Pharma Consolidated December 2020 Net Sales at Rs 8,836.78 crore, up 8.36% Y-o-Y

9.55 am | 02 Feb 2021 |  Source: Moneycontrol.com

NULL...

Sun Pharma Standalone December 2020 Net Sales at Rs 3,388.02 crore, up 12.43% Y-o-Y

9.11 am | 02 Feb 2021 |  Source: Moneycontrol.com

NULL...

Sun Pharma: Sustained traction in speciality to be a re-rating driver

12.42 pm | 31 Jan 2021 |  Source: Moneycontrol.com

Sun Pharma's India business is expected to gain traction as sub-chronic and acute therapies pick up with the opening up of clinics/OPDs. This is l...

Sun Pharma beats estimates in Q3 as profit doubles to Rs 1,852.5 crore

2.29 pm | 29 Jan 2021 |  Source: Moneycontrol.com

The company announced an interim dividend of Rs 5.50 per share....

Sun Pharma's profit, revenue to rise in Q3; EBITDA margin may remain stable

7.33 am | 29 Jan 2021 |  Source: Moneycontrol.com

Brokerage firm Motilal Oswal Financial Services expects a 65.7 percent YoY rise in adjusted net profit and a 7.3 percent YoY rise in revenue for the q...

Sun Pharma Q3 PAT seen up 56.7% YoY to Rs. 1,431.5 cr: Yash Securities

1.03 pm | 22 Jan 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 7.7 percent Y-o-Y (up 2.7 percent Q-o-Q) to Rs. 8,782.1 crore, according to Yash Securities....

Sun Pharma Q3 PAT seen up 44.4% YoY to Rs 1,319 cr: ICICI Direct

8.17 pm | 18 Jan 2021 |  Source: Moneycontrol.com

Net Sales are expected to increase by 5.9 percent Y-o-Y (up 1 percent Q-o-Q) to Rs. 8,636 crore, according to ICICI Direct....

Buy Sun Pharmaceutical Industries: target of Rs 660 : Sharekhan

2.27 pm | 15 Dec 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 660 in its research report dat...

Buy Sun Pharmaceutical Industries; target of Rs 585: ICICI Direct

1.40 pm | 07 Nov 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 585 in its research report ...

Buy Sun Pharmaceutical Industries; target of Rs 597: Prabhudas Lilladher

4.44 pm | 06 Nov 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 597 in its research ...

1 2
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.